Siemens Medical Systems' nuclear medicine group of Hoffman Estates, IL, rolled into the Radiological Society of North America meeting last month with a new offering in its E.Cam line. The company introduced E.Cam Cardiac Imaging System for dedicated
Siemens Medical Systems' nuclear medicine group of Hoffman Estates, IL, rolled into the Radiological Society of North America meeting last month with a new offering in its E.Cam line. The company introduced E.Cam Cardiac Imaging System for dedicated cardiac SPECT applications and cardiac perfusion studies. The new camera is part of the group's ongoing effort to reach market niches by segmenting its gamma camera lineup.
The new E.Cam has detector heads that can be positioned in both 90 and 76 configurations for automatic body contouring, and its cardiology software package includes the Advanced Emory Cardiac Toolbox. Like other E.Cams, it employs a workstation based on Apple's Macintosh G3 computer.
The cardiac system adds a fifth camera to the company's other E.Cam offerings: a variable-angle system, a dual-head, 180 unit, a single-head camera, and a coincidence unit. Siemens expects the new E.Cam to list in the $280,000 to $340,000 range.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.